Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016 (2016), Article ID 6273298, 8 pages
http://dx.doi.org/10.1155/2016/6273298
Clinical Study

Myoinositol Improves Embryo Development in PCOS Patients Undergoing ICSI

Diagnostic Techniques Unit, Department of Health Sciences, Medical University of Lublin, Lublin, Poland

Received 8 July 2016; Revised 26 August 2016; Accepted 31 August 2016

Academic Editor: Vittorio Unfer

Copyright © 2016 Artur Wdowiak. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Unfer, S. Proietti, G. Gullo, G. Porcaro, G. Carlomagno, and M. Bizzarri, “Polycystic ovary syndrome: features, diagnostic criteria and treatments,” Endocrinology & Metabolic Syndrome, vol. 3, article 136, 2014. View at Publisher · View at Google Scholar
  2. V. Unfer and G. Porcaro, “Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome,” Expert Review of Clinical Pharmacology, vol. 7, no. 5, pp. 623–631, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Bizzarri and G. Carlomagno, “Inositol: History of an effective therapy for Polycystic Ovary Syndrome,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 13, pp. 1896–1903, 2014. View at Google Scholar · View at Scopus
  4. S. Shorakae, J. Boyle, and H. Teede, “Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about,” Internal Medicine Journal, vol. 44, no. 8, pp. 720–726, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Y. J. Huang and Z. Rosenwaks, “In vitro fertilisation treatment and factors affecting success,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 26, no. 6, pp. 777–788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Gougeon, “Regulation of ovarian follicular development in primates: facts and hypotheses,” Endocrine Reviews, vol. 17, no. 2, pp. 121–155, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Agarwal, A. Aponte-Mellado, B. J. Premkumar, A. Shaman, and S. Gupta, “The effects of oxidative stress on female reproduction: a review,” Reproductive Biology and Endocrinology, vol. 10, article 49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Bausenwein, H. Serke, K. Eberle et al., “Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women,” Molecular Human Reproduction, vol. 16, no. 2, pp. 117–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Jakimiuk and J. Szamatowicz, “The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders,” Ginekologia Polska, vol. 85, no. 1, pp. 54–57, 2014. View at Google Scholar · View at Scopus
  10. P. Křepelka, “Myo-inositol in the treatment of polycystic ovary syndrome,” Ceska Gynekologie, vol. 79, no. 3, pp. 242–246, 2014. View at Google Scholar · View at Scopus
  11. T. T. Y. Chiu, M. S. Rogers, E. L. K. Law, C. M. Briton-Jones, L. P. Cheung, and C. J. Haines, “Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality,” Human Reproduction, vol. 17, no. 6, pp. 1591–1596, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Papaleo, V. Unfer, J.-P. Baillargeon, F. Fusi, F. Occhi, and L. De Santis, “Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial,” Fertility & Sterility, vol. 91, no. 5, pp. 1750–1754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Gerli, M. Mignosa, and G. C. Di Renzo, “Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial,” European Review for Medical and Pharmacological Sciences, vol. 7, no. 6, pp. 151–159, 2003. View at Google Scholar · View at Scopus
  14. V. Unfer, G. Carlomagno, P. Rizzo, E. Raffone, and S. Roseff, “Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 4, pp. 452–457, 2011. View at Google Scholar · View at Scopus
  15. A. Bevilacqua, G. Carlomagno, S. Gerli et al., “Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology-assisted reproduction technology,” Gynecological Endocrinology, vol. 31, no. 6, pp. 441–446, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Nel-Themaat and Z. P. Nagy, “A review of the promises and pitfalls of oocyte and embryo metabolomics,” Placenta, vol. 32, supplement 3, pp. S257–S263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-D. Jiang, K. Hu, Y. Liu et al., “Dietary myo-inositol modulates immunity through antioxidant activity and the Nrf2 and E2F4/cyclin signalling factors in the head kidney and spleen following infection of juvenile fish with Aeromonas hydrophila,” Fish and Shellfish Immunology, vol. 49, pp. 374–386, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kurus, C. Karakaya, M. H. Karalok, G. To, and J. Johnson, “The control of oocyte survival by intrinsic and extrinsic factors,” Advances in Experimental Medicine and Biology, vol. 761, pp. 7–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Ashwood-Smith and R. G. Edwards, “DNA repair by oocytes,” Molecular Human Reproduction, vol. 2, no. 1, pp. 46–51, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Inbar-Feigenberg, S. Choufani, D. T. Butcher, M. Roifman, and R. Weksberg, “Basic concepts of epigenetics,” Fertility & Sterility, vol. 99, no. 3, pp. 607–615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Whitelaw, S. Bhattacharya, G. Hoad, G. W. Horgan, M. Hamilton, and P. Haggarty, “Epigenetic status in the offspring of spontaneous and assisted conception,” Human Reproduction, vol. 29, no. 7, pp. 1452–1458, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Azzarello, T. Hoest, and A. L. Mikkelsen, “The impact of pronuclei morphology and dynamicity on live birth outcome after time-lapse culture,” Human Reproduction, vol. 27, no. 9, pp. 2649–2657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Kirkegaard, U. S. Kesmodel, J. J. Hindkjær, and H. J. Ingerslev, “Time-lapse parameters as predictors of blastocyst development and pregnancy outcome in embryos from good prognosis patients: a prospective cohort study,” Human Reproduction, vol. 28, no. 10, pp. 2643–2651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. K. Seleem, A. A. El Refaeey, D. Shaalan, Y. Sherbiny, and A. Badawy, “Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection,” Journal of Assisted Reproduction and Genetics, vol. 31, no. 4, pp. 499–504, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Muñoz, M. Cruz, P. Humaidan, N. Garrido, I. Pérez-Cano, and M. Meseguer, “Dose of recombinant FSH and oestradiol concentration on day of HCG affect embryo development kinetics,” Reproductive BioMedicine Online, vol. 25, no. 4, pp. 382–389, 2012. View at Publisher · View at Google Scholar · View at Scopus